Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpfizer.com
Get the latest updates from directly as they happen.
Follow now 42 followers
Latest posts
Last updated almost 2 years ago
Pfizer to Acquire Biohaven Pharmaceuticals
almost 2 years ago
Pfizer to Acquire Biohaven Pharmaceuticals Anonymous (not verified) Tue, 05/10/2022 - 06:45...
Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis
almost 2 years ago
Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA)...
Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in HR+, HER2- Metastatic Breast Cancer at ESMO Breast Cancer 2022
almost 2 years ago
Pfizer Presents Positive Real-World Evidence for First-Line IBRANCE® (palbociclib) Combination Therapy in...
Pfizer Reports First-Quarter 2022 Results
almost 2 years ago
Pfizer Reports First-Quarter 2022 Results Anonymous (not verified) Tue, 05/03/2022 - 06:45...
Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies
almost 2 years ago
Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation...
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer
almost 2 years ago
Zentalis Pharmaceuticals Announces $25 Million Equity Investment from Pfizer deliesschef Mon, 05/02/2022...
Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVIDTM for Post-Exposure Prophylactic Use
almost 2 years ago
Pfizer Shares Top-Line Results from Phase 2/3 EPIC-PEP Study of PAXLOVIDTM for...
Pfizer Announces 2022 Shareholder Meeting Preliminary Results
almost 2 years ago
Pfizer Announces 2022 Shareholder Meeting Preliminary Results kimkevin Thu, 04/28/2022 - 15:26...
Pfizer Declares Second-Quarter 2022 Dividend
almost 2 years ago
Pfizer Declares Second-Quarter 2022 Dividend Anonymous (not verified) Thu, 04/28/2022 - 08:00...
Pfizer to Open First U.S. Sites in Phase 3 Trial of Investigational Gene Therapy for Ambulatory Patients with Duchenne Muscular Dystrophy
almost 2 years ago
Pfizer to Open First U.S. Sites in Phase 3 Trial of Investigational...
Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine
almost 2 years ago
Pfizer and Biohaven’s VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European...
Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age
almost 2 years ago
Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a...